Lung Cancer in the Era of COVID-19
The programme is designed to offer an expert opinion exchange and provide some practical approaches for management of lung cancer during the COVID-19 pandemic.
Lung Cancer in the Era of COVID-19
Chair: Solange Peters
Speakers: Alfredo Addeo, Antonio Passaro
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
Programme
- Introduction, Solange Peters, MD, PhD - CHUV, Lausanne University, Lausanne, Switzerland
- Case 1: Immune checkpoint dilemma during the COVID-19 pandemic, Alfredo Addeo, MD - University Hospital of Geneva, Geneva, Switzerland
- Case 2: Management of lung cancer according to the recent ESMO COVID-19 recommendations, Solange Peters, MD, PhD - CHUV, Lausanne University, Lausanne, Switzerland
-
Discussion, Antonio Passaro, MD, PhD - European Institute of Oncology, Milan, Italy
Solange Peters, MD, PhD - CHUV, Lausanne University, Lausanne, Switzerland
Alfredo Addeo, MD - University Hospital of Geneva, Geneva, Switzerland - Closing Remarks, Solange Peters, MD, PhD - CHUV, Lausanne University, Lausanne, Switzerland
Learning objectives
- Understand the impact of the COVID-19 pandemic in the management of lung cancer patients
- Review the recent ESMO adapted recommendations on lung cancer in the COVID-19 era
- Present a case of lung cancer patient
- Discuss the case of lung cancer patient under the guidance of a moderator senior expert, author of the ESMO COVID-19 recommendations assisted with the speakers’ panel
Supporting Literature
Passaro A, Addeo A, Von Garnier C, et al. ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer. ESMO Open 2020; 5:e000820. doi:10.1136/ esmoopen-2020-000820
*The ESMO Webinar Series is freely available to all healthcare professionals working in Oncology
